Anne Beaufour was born in 1963 in Clarens, Switzerland, France. She and her brother Henri inherited a 76% stake in Ipsen, France's second-largest pharmaceutical company, from their grandfather Henri Beaufour. When their father Albert Beaufour died in 2000, the siblings split the stake, with Anne and Henri now controlling 57%. Anne sits on the board of Ipsen, which reported 2015 revenues of $1.6 billion, and holds a bachelor's degree in geology from the University of Paris Orsay.
Anne Beaufour is a member of Healthcare
Anne Beaufour, a prominent figure in the healthcare industry in France, is estimated to have a net worth of $2.7 billion in 2024. Known for her significant contributions to the field, Beaufour has gained substantial wealth through her involvement in healthcare initiatives and investments. Her expertise and influence have propelled her to achieve remarkable success, making her one of the wealthiest individuals in France. As an influential figure in the sector, Beaufour continues to make valuable contributions towards improving healthcare and positively impacting the lives of many.
2014
$1 Billion
2015
$1.2 Billion
2016
$1.3 Billion
2017
$1.9 Billion
2018
$3.34 Billion
Some Anne Beaufour images
Biography/Timeline
1965
Anne Gilberte Marie Beaufour was born in January 1965, the daughter of Albert Beaufour who died in 2000, and grandson of Henri Beaufour, the founder of Ipsen, France's second-largest pharmaceutical company. She has a bachelor's degree in geology from the University of Paris-Sud.
2000
When Albert Beaufour died in 2000, the family's 76% stake was split between three siblings, and sister Veronica sold her 6% stake. Anne and her brother Henri control 57% of Ipsen, and both sit on its board.
2016
As of April 2016, her net worth is US$1.45 billion.